MX2020004425A - Síntesis de derivados de éster boronato y usos de estos. - Google Patents
Síntesis de derivados de éster boronato y usos de estos.Info
- Publication number
- MX2020004425A MX2020004425A MX2020004425A MX2020004425A MX2020004425A MX 2020004425 A MX2020004425 A MX 2020004425A MX 2020004425 A MX2020004425 A MX 2020004425A MX 2020004425 A MX2020004425 A MX 2020004425A MX 2020004425 A MX2020004425 A MX 2020004425A
- Authority
- MX
- Mexico
- Prior art keywords
- synthesis
- ester derivatives
- boronate ester
- formula
- methods
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- -1 boronate ester Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 abstract 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 abstract 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical class OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229910052707 ruthenium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/46—Ruthenium, rhodium, osmium or iridium
- B01J23/462—Ruthenium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Catalysts (AREA)
Abstract
En la presente descripción se describen los métodos para la preparación de derivados de boronato en la síntesis de compuestos antimicrobianos y sus usos. En la presente descripción se describen los métodos para preparar un compuesto de la Fórmula (B) mediante la reducción del grupo cetona del compuesto cetoéster de la Fórmula (A), y la reducción puede realizarse mediante el uso de un sistema catalítico que se basa en Rutenio o mediante el uso de un sistema de biorreducción de la alcohol deshidrogenasa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762580343P | 2017-11-01 | 2017-11-01 | |
PCT/US2018/058143 WO2019089542A1 (en) | 2017-11-01 | 2018-10-30 | Synthesis of boronate ester derivatives and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020004425A true MX2020004425A (es) | 2020-08-06 |
Family
ID=66245250
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020004425A MX2020004425A (es) | 2017-11-01 | 2018-10-30 | Síntesis de derivados de éster boronato y usos de estos. |
MX2023000529A MX2023000529A (es) | 2017-11-01 | 2020-07-13 | Sintesis de derivados de ester boronato y usos de estos. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023000529A MX2023000529A (es) | 2017-11-01 | 2020-07-13 | Sintesis de derivados de ester boronato y usos de estos. |
Country Status (15)
Country | Link |
---|---|
US (2) | US11999757B2 (es) |
EP (1) | EP3704130A4 (es) |
JP (1) | JP7480050B2 (es) |
KR (1) | KR20200076730A (es) |
CN (1) | CN111556872B (es) |
AU (1) | AU2018360502B2 (es) |
BR (1) | BR112020008498A2 (es) |
CA (1) | CA3080763A1 (es) |
CL (1) | CL2020001143A1 (es) |
CO (1) | CO2020006299A2 (es) |
JO (1) | JOP20200101A1 (es) |
MX (2) | MX2020004425A (es) |
PH (1) | PH12020550544A1 (es) |
SG (1) | SG11202003762VA (es) |
WO (1) | WO2019089542A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202003762VA (en) | 2017-11-01 | 2020-05-28 | Melinta Therapeutics Inc | Synthesis of boronate ester derivatives and uses thereof |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
JP2852545B2 (ja) | 1989-11-14 | 1999-02-03 | チッソ株式会社 | 複数の不斉点を持つ光学活性化合物および製造法 |
CA2165996C (en) | 1995-12-22 | 2002-01-29 | Murray Douglas Bailey | Stereoselective preparation of 2-substituted succinic derivatives |
FR2745288B1 (fr) | 1996-02-27 | 1998-04-17 | Adir | Nouveaux derives de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
DE19917979A1 (de) | 1999-04-21 | 2000-10-26 | Clariant Gmbh | Verfahren zur Herstellung von substituierten Phenyl-boronsäuren |
USRE39333E1 (en) | 1999-06-04 | 2006-10-10 | Kaneka Corporation | Process for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives |
DE10032017A1 (de) | 2000-07-01 | 2002-01-10 | Clariant Gmbh | Verfahren zur Herstellung hochreiner Formylphenylboronsäuren |
DE10112401A1 (de) * | 2001-03-13 | 2002-09-19 | Degussa | Alkohol-Dehydrogenase und deren Verwendung |
DE10119274A1 (de) * | 2001-04-20 | 2002-10-31 | Juelich Enzyme Products Gmbh | Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen |
ES2544579T3 (es) * | 2002-07-30 | 2015-09-01 | Takasago International Corporation | Procedimiento de producción de un beta-aminoácido ópticamente activo |
TWI372725B (en) | 2004-01-30 | 2012-09-21 | Semequip Inc | Methods of synthesis of isotopically enriched borohydride and methods of synthesis of isotopically enriched boranes |
DE102004022397A1 (de) * | 2004-05-06 | 2005-12-01 | Consortium für elektrochemische Industrie GmbH | Chirale C2-symmetrische Biphenyle, deren Herstellung sowie Metallkomplexe enthaltend diese Liganden und deren Verwendung als Katalysatoren in chirogenen Synthesen |
WO2007034909A1 (ja) * | 2005-09-22 | 2007-03-29 | Kaneka Corporation | (3r,5r)-7-アミノ-3,5-ジヒドロキシヘプタン酸誘導体の製造法 |
GB2474687A (en) | 2009-10-23 | 2011-04-27 | Phoenix Chemicals Ltd | A continuous process for the production of (R)-6-cyano-5-hydroxy-3-oxo-hexanoic acid tert-butyl ester (and derivatives) |
ES2691468T3 (es) * | 2010-08-10 | 2018-11-27 | Rempex Pharmaceuticals, Inc. | Derivados de éster del ácido borónico cíclicos y usos terapéuticos de los mismos |
WO2013056163A1 (en) | 2011-10-14 | 2013-04-18 | The Regents Of The University Of California | Beta-lactamase inhibitors |
EP2814483A2 (en) * | 2012-02-15 | 2014-12-24 | Rempex Pharmaceuticals, Inc. | Methods of treating bacterial infections |
US20150105562A1 (en) | 2012-08-20 | 2015-04-16 | Manac Inc. | Method for preparing borinic acid derivatives and novel borinic acid derivatives |
CN102965403A (zh) | 2012-11-19 | 2013-03-13 | 苏州汉酶生物技术有限公司 | (3r,5s)-6-氯-3,5-二羟基己酸叔丁酯的生物制备方法 |
RU2654692C2 (ru) * | 2012-12-07 | 2018-05-22 | Венаторкс Фармасьютикалс, Инк. | Ингибиторы бета-лактамаз |
CA2927706C (en) | 2013-11-05 | 2018-05-29 | Bracco Imaging Spa | Process for the preparation of iopamidol |
DK3140310T3 (da) | 2014-05-05 | 2019-10-21 | Rempex Pharmaceuticals Inc | Syntese af boronatsalte og brug deraf |
SG11202003762VA (en) | 2017-11-01 | 2020-05-28 | Melinta Therapeutics Inc | Synthesis of boronate ester derivatives and uses thereof |
-
2018
- 2018-10-30 SG SG11202003762VA patent/SG11202003762VA/en unknown
- 2018-10-30 MX MX2020004425A patent/MX2020004425A/es unknown
- 2018-10-30 EP EP18874877.6A patent/EP3704130A4/en active Pending
- 2018-10-30 CA CA3080763A patent/CA3080763A1/en active Pending
- 2018-10-30 JP JP2020543266A patent/JP7480050B2/ja active Active
- 2018-10-30 BR BR112020008498-0A patent/BR112020008498A2/pt active Search and Examination
- 2018-10-30 KR KR1020207015638A patent/KR20200076730A/ko not_active Application Discontinuation
- 2018-10-30 AU AU2018360502A patent/AU2018360502B2/en active Active
- 2018-10-30 WO PCT/US2018/058143 patent/WO2019089542A1/en active Application Filing
- 2018-10-30 CN CN201880079247.3A patent/CN111556872B/zh active Active
- 2018-10-30 US US16/760,369 patent/US11999757B2/en active Active
- 2018-10-30 JO JOP/2020/0101A patent/JOP20200101A1/ar unknown
- 2018-10-31 US US16/176,302 patent/US20190127396A1/en not_active Abandoned
-
2020
- 2020-04-30 CL CL2020001143A patent/CL2020001143A1/es unknown
- 2020-05-01 PH PH12020550544A patent/PH12020550544A1/en unknown
- 2020-05-26 CO CONC2020/0006299A patent/CO2020006299A2/es unknown
- 2020-07-13 MX MX2023000529A patent/MX2023000529A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN111556872A (zh) | 2020-08-18 |
BR112020008498A2 (pt) | 2020-10-20 |
CA3080763A1 (en) | 2019-05-09 |
US20190127396A1 (en) | 2019-05-02 |
KR20200076730A (ko) | 2020-06-29 |
AU2018360502A1 (en) | 2020-06-04 |
CN111556872B (zh) | 2024-05-10 |
WO2019089542A1 (en) | 2019-05-09 |
CO2020006299A2 (es) | 2020-06-09 |
EP3704130A4 (en) | 2021-07-07 |
EP3704130A1 (en) | 2020-09-09 |
JP7480050B2 (ja) | 2024-05-09 |
MX2023000529A (es) | 2023-02-13 |
JP2021501205A (ja) | 2021-01-14 |
SG11202003762VA (en) | 2020-05-28 |
US20200308197A1 (en) | 2020-10-01 |
US11999757B2 (en) | 2024-06-04 |
CL2020001143A1 (es) | 2020-10-30 |
AU2018360502B2 (en) | 2024-05-02 |
PH12020550544A1 (en) | 2021-03-22 |
JOP20200101A1 (ar) | 2022-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY38070A (es) | Derivados de quinazolina y piridopirimidina sustituidos útiles como agentes anticáncer | |
UY38076A (es) | Derivados de tetrahidroquinazolina útiles como agentes anticáncer | |
DOP2019000165A (es) | Anticuerpos anti-ox40 y sus usos | |
DOP2018000268A (es) | Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos | |
CL2017001675A1 (es) | Derivados de quinazolina utilizados para tratar el vih | |
BR112017009601A2 (pt) | derivados de aminoácidos e seus usos | |
AR093244A1 (es) | Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2 | |
CR20150472A (es) | USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRANSTORNOS RELACIONADOS CON LA PI3Kd | |
BR112016000489A8 (pt) | composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos | |
CU24272B1 (es) | Derivados de tetrahidropirido-pirimidina como inhibidores de mek | |
PE20142456A1 (es) | COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks | |
ECSP10010496A (es) | Derivado heterociclico fusionado y su uso | |
GT200600394A (es) | Benzimidazoles sustituidos y metodos para usarlos como inhibidores de las quinasas asociadas con la tumorigenesis. | |
UY37015A (es) | Inhibidores de la tirosina quinasa de bruton y métodos de su uso | |
DOP2019000290A (es) | Inhibidores de quinasa y usos de los mismos | |
DOP2016000047A (es) | Compuestos y composiciones como inhibidores de la mek | |
AR103077A1 (es) | Método para la producción de un sistema de administración farmacéutica | |
UY37016A (es) | Inhibidores de la tirosina quinasa de bruton y métodos de su uso | |
BR112015026847A2 (pt) | tiazóis e usos dos mesmos | |
DOP2016000308A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
CL2018003121A1 (es) | Inhibidores del potenciador del homólogo zeste 2. | |
UY36195A (es) | Amidas de benzoxazinona como reguladores del receptor mineralocorticoide | |
CY1122423T1 (el) | Παραγωγα πυριμιδινης χρησιμα ως εκλεκτικοι αναστολεις jak3 kai/ή jak1 | |
CL2020003015A1 (es) | Conversión a escala preparativa de goniautoxinas en neosaxitoxina | |
CO2020006299A2 (es) | Síntesis de derivados de éster boronato y usos de estos |